ACT has $15MM approx. in cash which is a drop in a bucket as to what they will need to complete 2 trials and possibly start another in Europe. They doubled their employees recently and will be burning through cash at a much faster pace than ever before once trials begin. To think Socius financing won't be needed would be a major stretch, imo.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.